Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595

Nicola Sgherza¹, Olga Battisti¹, Paola Curci¹, Concetta Conticello², Salvatore Palmieri³, Daniele Derudas⁴, Candida Germano⁵, Enrica Antonia Martino⁶, Giuseppe Mele⁷, Roberta Della Pepa⁸, Francesca Fazio⁹, Anna Mele¹⁰, Bernardo Rossini¹¹, Giulia Palazzo¹², Daniela Roccotelli¹³, Simona Rasola¹⁴, Maria Teresa Petrucci⁹, Domenico Pastore⁷, Giuseppe Tarantini⁵, Fabrizio Pane⁸, Massimo Gentile^{6

15}, Francesco Di Raimondo^{2

16}, Emanuela Resta¹⁷, Pellegrino Musto^{1

14}

Affiliations

¹ Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, 70124 Bari, Italy.
² Division of Hematology and Stem Cell Transplantation, Policlinico "G. Rodolico-San Marco", 95123 Catania, Italy.
³ Hematology Unit, Ospedale Cardarelli, 80131 Napoli, Italy.
⁴ Department of Hematology, Businco Hospital, 09121 Cagliari, Italy.
⁵ Hematology Unit, "Dimiccoli" Hospital, 70051 Barletta, Italy.
⁶ Department of Onco-Hematology, Hematology Unit, Azienda Ospedaliera Annunziata, 87100 Cosenza, Italy.
⁷ Hematology Unit, "Perrino" Hospital, 72100 Brindisi, Italy.
⁸ Hematology-Department of Clinical Medicine and Surgery, University Hospital "Federico II", 80131 Napoli, Italy.
⁹ Department of Translational and Precision Medicine Hematology, Sapienza University, 00185 Roma, Italy.
¹⁰ Hematology Unit, "Cardinale Panico" Hospital, 70039 Tricase, Italy.
¹¹ Hematology and Cell Therapy Unit, IRCCS Istituto Tumori "Giovanni Paolo II" Bari, 70124 Bari, Italy.
¹² Haematology Unit, Ospedale G. Moscati, 74010 Taranto, Italy.
¹³ Department of Hematology and Bone Marrow Transplant, IRCSS "Casa Sollievo Della Sofferenza", 71013 Foggia, Italy.
¹⁴ Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, 70121 Bari, Italy.
¹⁵ Department of Pharmacy, Health and Nutritional Science, University of Calabria, 87036 Rende, Italy.
¹⁶ Department of General Surgery and Medical-Surgical Specialties, Hematology Section, University of Catania, 95124 Catania, Italy.
¹⁷ Department of Clinical and Molecular Medicine, Sapienza University, 00185 Roma, Italy.

PMID: 40573328
PMCID: PMC12196246
DOI: 10.3390/ph18060858

Published Erratum

Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595

Nicola Sgherza et al. Pharmaceuticals (Basel). 2025.

. 2025 Jun 9;18(6):858.

doi: 10.3390/ph18060858.

Authors

Affiliations

¹ Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, 70124 Bari, Italy.
² Division of Hematology and Stem Cell Transplantation, Policlinico "G. Rodolico-San Marco", 95123 Catania, Italy.
³ Hematology Unit, Ospedale Cardarelli, 80131 Napoli, Italy.
⁴ Department of Hematology, Businco Hospital, 09121 Cagliari, Italy.
⁵ Hematology Unit, "Dimiccoli" Hospital, 70051 Barletta, Italy.
⁶ Department of Onco-Hematology, Hematology Unit, Azienda Ospedaliera Annunziata, 87100 Cosenza, Italy.
⁷ Hematology Unit, "Perrino" Hospital, 72100 Brindisi, Italy.
⁸ Hematology-Department of Clinical Medicine and Surgery, University Hospital "Federico II", 80131 Napoli, Italy.
⁹ Department of Translational and Precision Medicine Hematology, Sapienza University, 00185 Roma, Italy.
¹⁰ Hematology Unit, "Cardinale Panico" Hospital, 70039 Tricase, Italy.
¹¹ Hematology and Cell Therapy Unit, IRCCS Istituto Tumori "Giovanni Paolo II" Bari, 70124 Bari, Italy.
¹² Haematology Unit, Ospedale G. Moscati, 74010 Taranto, Italy.
¹³ Department of Hematology and Bone Marrow Transplant, IRCSS "Casa Sollievo Della Sofferenza", 71013 Foggia, Italy.
¹⁴ Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, 70121 Bari, Italy.
¹⁵ Department of Pharmacy, Health and Nutritional Science, University of Calabria, 87036 Rende, Italy.
¹⁶ Department of General Surgery and Medical-Surgical Specialties, Hematology Section, University of Catania, 95124 Catania, Italy.
¹⁷ Department of Clinical and Molecular Medicine, Sapienza University, 00185 Roma, Italy.

PMID: 40573328
PMCID: PMC12196246
DOI: 10.3390/ph18060858

Abstract

In the original publication [...].

PubMed Disclaimer

Erratum for

Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study.
Sgherza N, Battisti O, Curci P, Conticello C, Palmieri S, Derudas D, Germano C, Martino EA, Mele G, Della Pepa R, Fazio F, Mele A, Rossini B, Palazzo G, Roccotelli D, Rasola S, Petrucci MT, Pastore D, Tarantini G, Pane F, Gentile M, Di Raimondo F, Resta E, Musto P. Sgherza N, et al. Pharmaceuticals (Basel). 2025 Apr 19;18(4):595. doi: 10.3390/ph18040595. Pharmaceuticals (Basel). 2025. PMID: 40284030 Free PMC article.

References

1. Sgherza N., Battisti O., Curci P., Conticello C., Palmieri S., Derudas D., Germano C., Martino E.A., Mele G., Della Pepa R., et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals. 2025;18:595. doi: 10.3390/ph18040595. - DOI - PMC - PubMed

Publication types

Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Affiliations

Authors

Affiliations

Abstract

Erratum for

References

Publication types